Methicillin-resistant Staphylococcus aureus

Nature Reviews. Disease Primers
Andie S LeeStephan Harbarth

Abstract

Since the 1960s, methicillin-resistant Staphylococcus aureus (MRSA) has emerged, disseminated globally and become a leading cause of bacterial infections in both health-care and community settings. However, there is marked geographical variation in MRSA burden owing to several factors, including differences in local infection control practices and pathogen-specific characteristics of the circulating clones. Different MRSA clones have resulted from the independent acquisition of staphylococcal cassette chromosome mec (SCCmec), which contains genes encoding proteins that render the bacterium resistant to most β-lactam antibiotics (such as methicillin), by several S. aureus clones. The success of MRSA is a consequence of the extensive arsenal of virulence factors produced by S. aureus combined with β-lactam resistance and, for most clones, resistance to other antibiotic classes. Clinical manifestations of MRSA range from asymptomatic colonization of the nasal mucosa to mild skin and soft tissue infections to fulminant invasive disease with high mortality. Although treatment options for MRSA are limited, several new antimicrobials are under development. An understanding of colonization dynamics, routes of transmission, risk factors...Continue Reading

References

Jan 1, 1978·Medical Microbiology and Immunology·U HöfflerG Pulverer
Aug 1, 1995·Epidemiology and Infection·N H EriksenK Jensen
Jan 1, 1995·The Journal of Infectious Diseases·J A KluytmansH A Verbrugh
Apr 1, 1994·Antimicrobial Agents and Chemotherapy·C RyffelB Berger-Bächi
Jul 1, 1997·The Journal of Antimicrobial Chemotherapy·K HiramatsuF C Tenover
Aug 26, 1998·The New England Journal of Medicine·F D Lowy
Mar 17, 2000·Journal of Korean Medical Science
Jan 4, 2001·The New England Journal of Medicine·C von EiffG Peters
Feb 15, 2002·The New England Journal of Medicine·Henry ShinefieldRobert Naso
Dec 20, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Sara E CosgroveYehuda Carmeli
Sep 25, 2003·Archives of Internal Medicine·Vance G FowlerEugene Z Oddone
Sep 27, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Caroline Eva Wella HerrThomas Friedrich Eikmann
Feb 19, 2004·Drugs·Caroline FentonMonique P Curran
Oct 9, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kepler A DavisDuane R Hospenthal
Dec 23, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·John S FrancisJohn G Bartlett
Feb 4, 2005·The New England Journal of Medicine·Sophia V KazakovaDaniel B Jernigan
Apr 9, 2005·The New England Journal of Medicine·Scott K FridkinUNKNOWN Active Bacterial Core Surveillance Program of the Emerging Infections Program Network
Apr 9, 2005·The New England Journal of Medicine·Loren G MillerBrad Spellberg
Nov 29, 2005·The Lancet Infectious Diseases·Heiman F L WertheimJan L Nouwen
Dec 20, 2005·The Journal of Infectious Diseases·Matthew J KuehnertFred C Tenover
Feb 1, 2006·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ulrich SeyboldHenry M Blumberg
Feb 9, 2006·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Cassandra D Salgado, Barry M Farr
Feb 21, 2006·Emerging Infectious Diseases·Andreas VossMireille Wulf
Mar 30, 2006·Antimicrobial Agents and Chemotherapy·George SakoulasGeorge M Eliopoulos
Jun 17, 2006·Nature Reviews. Microbiology·Andreas Peschel, Hans-Georg Sahl
Jul 15, 2006·The Journal of Antimicrobial Chemotherapy·Carl Erik NordElisabeth Wahlund
Aug 18, 2006·The New England Journal of Medicine·Vance G FowlerUNKNOWN S. aureus Endocarditis and Bacteremia Study Group

❮ Previous
Next ❯

Citations

Feb 15, 2019·Current Medical Research and Opinion·Sebastiano LeoneMarco Fiore
Nov 18, 2018·The Journal of Infectious Diseases·Scott D Kobayashi, Frank R DeLeo
May 19, 2019·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Joana C MatosM Clara Gonçalves
Dec 4, 2019·Nature Chemical Biology·Lina M GonzálezChristopher A Voigt
Feb 23, 2020·Toxins·Assia MairiJean-Philippe Lavigne
Dec 11, 2019·Current Topics in Medicinal Chemistry·Juliana S NovaisFernando de C da Silva
Apr 28, 2020·Advanced Healthcare Materials·Liu YangJianyu Su
Dec 21, 2019·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Han-Wei LiChih-Ching Huang
Mar 13, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Stephen M BartEdward Cox
May 22, 2020·Journal of Food Protection·Joelza Silva CarvalhoRogeria Comastri DE Castro Almeida
May 29, 2020·Antioxidants & Redox Signaling·Viktoria Rungelrath, Frank R DeLeo
Jun 11, 2020·The Journal of Biological Chemistry·J Andrew N AlexanderNatalie C J Strynadka
Jul 22, 2020·Infection and Immunity·Adeline PeignierDane Parker
Oct 5, 2018·The Journal of Antimicrobial Chemotherapy·Jasmine CoppensSurbhi Malhotra-Kumar
Jul 31, 2019·Proceedings of the National Academy of Sciences of the United States of America·Wooseong KimEleftherios Mylonakis
Dec 5, 2019·Scientific Reports·Isana Maria de Souza Feitosa LimaLuís Cláudio Nascimento da Silva
Jul 8, 2020·International Journal of Molecular Sciences·Laísa CordeiroEdeltrudes Lima
Nov 30, 2018·Nature·Michael S Gilmore, Ona K Miller
Jan 18, 2019·Science Translational Medicine·Rita ChanVictor J Torres
Jan 29, 2019·Frontiers in Genetics·Sofia Santos CostaIsabel Couto
Sep 26, 2019·Frontiers in Microbiology·Anthonymuthu SelvarajShunmugiah Karutha Pandian
Sep 22, 2019·International Journal of Molecular Sciences·Kai-Wei TangChih-Hua Tseng
Mar 12, 2020·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Motaharesadat HosseiniAzad Khaledi

❮ Previous
Next ❯

Methods Mentioned

BETA
ribotyping
electrophoresis
PCR
amputation

Software Mentioned

hVISA
VISA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.